Best Sevabertinib (Hyrnuo) Medicine in India

Sevabertinib (Hyrnuo) is a targeted anticancer treatment used to treat adults with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have specific HER2 (ERBB2) tyrosine kinase domain activating mutations and who have received prior systemic therapy. It belongs to a group of medicines called kinase inhibitors and works by blocking abnormal HER2 signaling involved in cancer-cell growth and survival, helping to slow disease progression.

Sevabertinib (Hyrnuo) should be taken exactly as prescribed by your doctor. It is taken orally with food according to the recommended treatment schedule. Swallow it whole with water and do not crush, chew, or break it. Regular medical check-ups and laboratory tests may be required to monitor your response to treatment, liver function, and overall health.

Common side effects of Sevabertinib (Hyrnuo) may include diarrhea, rash, nail changes, mouth sores, nausea, decreased appetite, fatigue, muscle or joint pain, and changes in liver or pancreatic enzyme levels. Sevabertinib may also cause serious lung, liver, eye, or pancreatic problems in some patients. Inform your doctor promptly if you develop breathing difficulties, persistent cough, severe diarrhea, vision changes, or other concerning symptoms. Before starting treatment, tell your doctor about your medical history and all medicines, vitamins, and supplements you are taking.

Treatment of HER2-Mutated Non-Small Cell Lung Cancer

Sevabertinib (Hyrnuo) is used to treat adults with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with specific activating HER2 (ERBB2) tyrosine kinase domain mutations who have received prior systemic therapy. It blocks abnormal HER2 signaling, helping to slow cancer-cell growth and disease progression.

Some side effects of Sevabertinib (Hyrnuo) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Sevabertinib (Hyrnuo)

Take Sevabertinib (Hyrnuo) exactly as prescribed by your doctor, usually once daily with food. Take it at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. Follow your doctor's instructions if you miss a dose or vomit after taking it. Continue treatment as recommended and attend regular medical check-ups and laboratory tests.

Sevabertinib (Hyrnuo) is a HER2 tyrosine kinase inhibitor that targets specific activating HER2 (ERBB2) mutations in cancer cells. It blocks abnormal HER2 signaling involved in cancer-cell growth and survival, helping to inhibit tumor growth and slow disease progression.

• Store Hyrnuo tablets at room temperature between 20°C and 25°C.
• Temperature excursions between 2°C and 30°C are permitted.
• Keep the tablets in their original container and close the container securely after use.
• Store the medicine out of the reach of children.

Alcohol CONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as nausea, fatigue, or dizziness. Follow your doctor's advice.

Pregnancy CONSULT YOUR DOCTOR

Hyrnuo may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the recommended period after the last dose.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment and for the recommended period after the last dose, as the effects on a breastfed child are not fully known.

Driving CONSULT YOUR DOCTOR

Avoid driving or operating machinery if you experience fatigue, dizziness, vision changes, or other effects that may impair your alertness.

Kidney CAUTION

Inform your doctor if you have kidney problems. Your doctor may monitor kidney function and provide appropriate medical care during treatment.

Liver CAUTION

Tell your doctor about any liver condition. Regular liver function tests may be required, and report yellowing of the skin or eyes, dark urine, or unusual tiredness promptly.

• Take Sevabertinib (Hyrnuo) exactly as prescribed and follow your doctor's treatment schedule carefully.
• Take it with food at approximately the same time each day for consistent treatment.
• Report new or worsening cough, breathing difficulties, or chest discomfort promptly.
• Inform your doctor about severe diarrhea, skin or nail changes, vision problems, or persistent mouth sores.
• Attend regular medical check-ups and laboratory tests to monitor liver function and other treatment-related effects.
• Read More About - Sevabertinib (Hyrnuo) from Pharma Five.

Pharma Five, may assist patients in importing Sevabertinib (Hyrnuo) in small quantities for personal medical use. For the import process, the applicant is required to submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).<br>

Pharma Five assists patients seeking Sevabertinib (Hyrnuo) by providing professional pharmaceutical consultancy and facilitation services to support access through appropriate import procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.